ADAR1 Capital Management’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$111K Buy
2024
Q4
Sell
2024
Q3
$287K Sell
2024
Q2
$337K Buy
2024
Q1
$338K Buy